Why Sanofi’s Fair Value Was Trimmed Sanofi’s fair value has been adjusted from about €104.87 to roughly €102.77, a small trim ...

The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

The first GLP-1 pill for obesity, semaglutide (Wegovy) tablets from drugmaker Novo Nordisk, launched in the U.S. ( CNBC) ...

The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...

Luckily for us, George Clooney found an incredibly clever workaround when he nabbed his star-making role as Dr. Doug Ross on ...

Jo McIntyre, founder of TTPNetwork and a former domestic abuse reduction coordinator, has been awarded the British Empire Medal (BEM) in the King’s New Year Honours. The award recognises her 28 years ...

CRISPR Therapeutics (NASDAQ:CRSP) is one of the best emerging technology stocks to invest in. On December 22, CRISPR Therapeutics released a comprehensive clinical update on zugocaptagene geleucel ...

Sanofi (SNYNF) announced an update on their ongoing clinical study.

Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet ...

Based on these postmarketing reports, the FDA is evaluating the need for further regulatory action. The Food and Drug Administration (FDA) is investigating the risk of developing neutralizing ...

The FDA has opened an investigation into Takeda’s recombinant protein med Adzynma following the reported death of a pediatric patient who received the drug. The probe comes as the regulator says it ...

Gamunex-C (immune globulin [human]) can cause mild to serious side effects. More common side effects include headache. If Gamunex-C’s side effects become bothersome for you or your child, ask the ...